Evidence map›Paper›PMID 31313970›Full record

ArticleJournal of feline medicine and surgery2020

Antiemetic effect of oral maropitant treatment before the administration of brimonidine ophthalmic solution in healthy cats.

Teppei Kanda, Chisato Toda, Haruka Morimoto, Yuki Shimizu, Takamasa Itoi, Kayo Furumoto, Yasuhiko Okamura, Eri Iwata

Open access · greenAbstract readRandomized Controlled Trial, Veterinary
In one paragraph

Article in Journal of feline medicine and surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Teppei KandaFaculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.ORCID 0000-0002-7103-3462
Chisato TodaDepartment of Comparative Animal Science, College of Life Science, Kurashiki University of Science and the Arts, Kurashiki, Okayama, Japan.
Haruka MorimotoDepartment of Comparative Animal Science, College of Life Science, Kurashiki University of Science and the Arts, Kurashiki, Okayama, Japan.
Yuki ShimizuFaculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Takamasa ItoiDepartment of Comparative Animal Science, College of Life Science, Kurashiki University of Science and the Arts, Kurashiki, Okayama, Japan.
Kayo FurumotoFaculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Yasuhiko OkamuraFaculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Eri IwataFaculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Okayama University of Science · JPKurashiki University of Science and the Arts · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to investigate the antiemetic, behavioural and physiological effects of oral maropitant treatment before the administration of brimonidine ophthalmic solution in healthy cats.

methodsFive cats received oral maropitant 8 mg or no treatment (control) 18 h before the administration of one drop of brimonidine solution in both eyes. Each cat was administered each of the two treatments, with a washout period of 1 week. The incidence of emesis, retching, sialorrhoea and lip-licking after brimonidine administration was recorded, while behavioural and physiological parameters, including heart rate, mean blood pressure, respiratory frequency and rectal temperature, were recorded before and 0, 30, 60, 90, 120, 180 and 240 mins after brimonidine administration.

resultsEmesis and retching were not observed when maropitant was administered. However, 4/5 cats exhibited vomiting and retching in the absence of maropitant pretreatment. The incidence of emesis and retching after brimonidine administration was significantly lower in the treatment group than in the control group. Sialorrhoea occurred in one cat in the control group, while all cats showed lip-licking after brimonidine administration. There were no significant differences in the incidence of sialorrhoea and lip-licking between the two groups. Although behaviour scores were comparable between the two groups, those obtained during heart rate, mean blood pressure and respiratory frequency measurements were significantly lower than the baseline scores; this indicated a sedative effect after brimonidine administration. The heart rate and mean blood pressure significantly decreased after brimonidine administration in both groups, while there were no intergroup differences in the heart rate, mean blood pressure, respiratory frequency and rectal temperature. CONCLUSIONS AND RELEVANCE: Oral maropitant treatment before the administration of brimonidine ophthalmic solution in cats can alleviate emesis and retching without affecting the sedative effects of brimonidine and important physiological parameters.

Indexed as

Administration, OralAnimalsAntiemeticsBrimonidine TartrateCatsCross-Over StudiesOphthalmic SolutionsQuinuclidinesReference ValuesAntiemeticsBrimonidine TartratemaropitantOphthalmic SolutionsQuinuclidinesanaesthesiaantiemeticBrimonidineemesismaropitantsedationα2-adrenoceptor

Identifiers

PMID31313970
PMCPMC10814329
OpenAlexW2957383983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.